Centers of Psychiatric Excellence

Centers of Psychiatric Excellence (COPE) is a management services organization (MSO) that provides administrative and advisory support to a network of independently operated psychiatric clinics across the United States. Founded by leading psychiatrists from institutions like Duke and Yale, the company specializes in evidence-based treatments for treatment-resistant mental health conditions, including depression, anxiety, and PTSD. COPE is particularly known for its expertise in ketamine infusion therapy and esketamine (Spravato) administration, as well as developing specialized therapeutic models like the COPE COVID-19 resiliency program. The organization focuses on bridging the gap between academic research and clinical practice to provide innovative care for the most difficult-to-treat psychiatric cases. Through its network, COPE offers a range of services including clinical research, patient registries, and specialized training for mental health professionals.